newsfilter
← Latest News
ACCESS Newswire·

Kadmon Announces Abstract Accepted for Presentation at the Society for Immunotherapy of Cancer's 35th Anniversary Annual Meeting

Kadmon Holdings, Inc. (NYSE:KDMN) announced today it will present preclinical data on its anti-PD-1/IL-15 fusion protein in development for oncology indications, at the Society for Immunotherapy of Cancer's (SITC 2020) 35th Anniversary Annual Meeting, taking place virtually November 9 - 14, 2020.